Notice Regarding Monthly Management Parameters for September 2026 | Anicom Holdings,Inc. (8715) timely disclosure

Worth reading

43Recurring

0–100. This measures how worthwhile something is to read, not how good or bad the company is.

Direction

Mixed performance

Direction inferred from the company’s description.

Scale

5716

¥ million

Wording

Definitive

How definitive the wording is.

Sales for this month

September 2026Fiscal year ending March 2027

Monthly Commentary

The company has disclosed monthly management parameters for the period from April through September of fiscal 2026. No comments have been provided on the reasons for individual increases or decreases.

Next Scheduled Disclosure

Disclosed around the middle of each month or later. Figures for June, September, December, and March are disclosed on the same day as the announcement of the quarterly results for each period.

Monthly trend for the same period last year

Month April / Net Premiums Written ¥5,134 million / Policies in force ¥1,297,369 million / Average renewal rate ¥88.5 million / どうぶつ健活 applications ¥20,749 million / Patents held ¥22 million, Month May / Net Premiums Written ¥5,424 million / Policies in force ¥1,308,167 million / Average renewal rate ¥88.2 million / どうぶつ健活 applications ¥23,085 million / Patents held ¥22 million, Month June / Net Premiums Written ¥5,220 million / Policies in force ¥1,318,043 million / Average renewal rate ¥88.2 million / どうぶつ健活 applications ¥19,134 million / Patents held ¥23 million, Month July / Net Premiums Written ¥5,175 million / Policies in force ¥1,326,765 million / Average renewal rate ¥88.4 million / どうぶつ健活 applications ¥20,123 million / Patents held ¥24 million, Month August / Net Premiums Written ¥5,332 million / Policies in force ¥1,337,652 million / Average renewal rate ¥88.4 million / どうぶつ健活 applications ¥22,258 million / Patents held ¥25 million, Month September / Net Premiums Written ¥5,387 million / Policies in force ¥1,347,456 million / Average renewal rate ¥88.4 million / どうぶつ健活 applications ¥21,294 million / Patents held ¥25 million

Scope of aggregation: The group

Sales for this month
Item	Details
Month Covered	September 2026
Fiscal Year Covered	Fiscal year ending March 2027
Scope of aggregation	The group
Key KPIs	Indicator name Net Premiums Written / Value ¥5,716 million / Year on year 106.1%, Indicator name Policies in force / Value 1,433,091 contracts / Year on year 106.4%, Indicator name Average renewal rate / Value 88.8 % / Year on year 100.5%, Indicator name Doubutsu Kenkatsu program (gut flora testing) applications / Value 16,701 contracts / Year on year 78.4%, Indicator name Patents held / Value 32 contracts / Year on year 128.0%, Indicator name JARVIS Tokyo sales / Value ¥86,376 thousand / Year on year Not disclosed
Monthly Commentary	The company has disclosed monthly management parameters for the period from April through September of fiscal 2026. No comments have been provided on the reasons for individual increases or decreases.
Monthly trend for the same period last year	Month April / Net Premiums Written ¥5,134 million / Policies in force ¥1,297,369 million / Average renewal rate ¥88.5 million / どうぶつ健活 applications ¥20,749 million / Patents held ¥22 million, Month May / Net Premiums Written ¥5,424 million / Policies in force ¥1,308,167 million / Average renewal rate ¥88.2 million / どうぶつ健活 applications ¥23,085 million / Patents held ¥22 million, Month June / Net Premiums Written ¥5,220 million / Policies in force ¥1,318,043 million / Average renewal rate ¥88.2 million / どうぶつ健活 applications ¥19,134 million / Patents held ¥23 million, Month July / Net Premiums Written ¥5,175 million / Policies in force ¥1,326,765 million / Average renewal rate ¥88.4 million / どうぶつ健活 applications ¥20,123 million / Patents held ¥24 million, Month August / Net Premiums Written ¥5,332 million / Policies in force ¥1,337,652 million / Average renewal rate ¥88.4 million / どうぶつ健活 applications ¥22,258 million / Patents held ¥25 million, Month September / Net Premiums Written ¥5,387 million / Policies in force ¥1,347,456 million / Average renewal rate ¥88.4 million / どうぶつ健活 applications ¥21,294 million / Patents held ¥25 million
Next Scheduled Disclosure	Disclosed around the middle of each month or later. Figures for June, September, December, and March are disclosed on the same day as the announcement of the quarterly results for each period.

Items this document does not state (15)

Net sales for the monthYear-on-year change in monthly net salesTotal-store sales, year on yearSame-Store Sales, Year on YearYear-on-Year Change in Customer CountYear-on-Year Change in Average Spend per CustomerCumulative Sales from Start of PeriodCumulative Year-on-Year Change from Start of PeriodYear-on-year change by categorySales by categoryNumber of Stores at Period-EndNumber of stores opened during the monthNumber of stores closed during the monthFactors Affecting the ChangeMeasures from the following month onward

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company has not provided an explanation for the reasons behind the changes in individual figures. The number of patents held is disclosed as a key metric for promoting Bio Insurtech.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.